Abstract
Piergiuseppe Agostoni. Considerations on safety and treatment of patients with chronic heart failure at high altitude. High Alt Med Biol 14:96-100, 2013. - Prognosis and quality of life of chronic heart failure (HF) patients have greatly improved over the last decade. Consequently, many patients are willing to spend leisure time at altitude, usually 1-β2-α- blocker, reduces the hypoxic ventilatory response through a reduction of the chemoreflex response, and it reduces alveolar-capillary gas diffusion, which is under control by β2-receptors. These actions are not shared by selective β1-blockers such as bisoprolol and nebivolol, which should be preferred for treatment of HF patients willing to spend time at altitude. In conclusion, spending time at altitude (
Original language | English |
---|---|
Pages (from-to) | 96-100 |
Number of pages | 5 |
Journal | High Altitude Medicine and Biology |
Volume | 14 |
Issue number | 2 |
DOIs | |
Publication status | Published - Jun 1 2013 |
ASJC Scopus subject areas
- Medicine(all)
- Physiology
- Public Health, Environmental and Occupational Health